Brief: Acurx Announces New Ibezapolstat Data On Anti-Recurrence Mechanisms In CDI At Prominent International Conference
01/07/2021 13:07
July 1 (Reuters) - Acrux Pharmaceuticals Inc ACXP.O :
* ACURX ANNOUNCES NEW IBEZAPOLSTAT DATA ON ANTI-RECURRENCE
MECHANISMS IN CDI AT PROMINENT INTERNATIONAL CONFERENCE
Source text for Eikon: ID:nPn9Yz07Da
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program